Cross-fund · 3 holders
FDMT
4D MOLECULAR THERAPEUTICS IN
CUSIP 35104E100
3
Tracked holders
$64.7M
Aggregate value
7,555,926
Shares
5
Active funds
Funds holding FDMT
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $38.6M | — | +80,427 | +2.0% |
| Vanguard | Institutional | Q4 2025 | $23.2M | — | +518,405 | +20.1% |
| Citadel | Multi-Strategy | Q1 2026 | $3.0M | — | +246,207 | +347.3% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -96,364 | EXITED |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -1,539,860 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.